Development and evaluation of a standardized ELISA for the determination of autoantibodies against c...
Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis
About this item
Full title
Author / Creator
Publisher
England: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
England: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
Sporadic inclusion body myositis (sIBM) is an autoimmune degenerative disease of the muscle, with inflammatory infiltrates and inclusion vacuoles. Its pathogenesis is not fully understood and the diagnosis is hampered by its imprecise characteristics, at times indistinguishable from other idiopathic inflammatory myopathies such as polymyositis and...
Alternative Titles
Full title
Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5114199
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5114199
Other Identifiers
ISSN
2038-0305
E-ISSN
2038-3274
DOI
10.1007/s13317-016-0088-8
